Investigating treatment dose
error due to beam attenuation
by a carbon fiber tabletop
W. Kenji Myint,a Malgorzata Niedbala, David Wilkins, and Lee H. Gerig
Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario Canada
kmyint@ottawahospital.on.caReceived 10 February 2006; accepted 13 June 2006
Carbon fiber is commonly used in radiation therapy for treatment tabletops and various immobilization and support devices, partially because it is generally perceived to be almost radiotransparent to high-energy photons. To avoid exposure to normal tissue during modern radiation therapy, one must deliver the radiation from all gantry angles; hence, beams often transit the couch proximal to the patient. The effects of the beam attenuation by the support structure of the couch are often neglected in the planning process. In this study, we investigate the attenuation of 6-MV and 18-MV photon beams by a Medtec (Orange City, IA) carbon fiber couch. We have determined that neglecting the attenuation of oblique treatment fields by the carbon fiber couch can result in localized dose reduction from 4% to 16%, depending on energy, field size, and geometry. Further, we investigate the ability of a commercial treatment-planning system (Theraplan Plus v3.8) to account for the attenuation by the treatment couch. Results show that incorporating the carbon fiber couch in the patient model reduces the dose error to less than 2%. The variation in dose reduction as a function of longitudinal couch position was also measured. In the triangular strut region of the couch, the attenuation varied ±0.5% following the periodic nature of the support structure. Based on these findings, we propose the routine incorporation of the treatment tabletop into patient treatment planning dose calculations.
PACS numbers: 87.53.Dq, 87.53.Mr
Key words: radiotherapy, couch attenuation, dose error
Corresponding author: Kenji Myint, Department of Medical Physics, Ottawa Hospital Regional Cancer Centre, 503 Smyth Rd., Ottawa, ON K1H 8L6 Canada; email: kmyint@ottawahospital.on.ca
I. INTRODUCTION
The growing use of carbon fiber materials in
radiation therapy is largely due to their high mechanical strength,
low specific density, and radiotranslucence.(1) These characteristics make carbon fiber
materials ideal for the patient support assembly. Prior to the use
of these materials for treatment couches, the patient support
structure consisted of a table mounted on steel rails or stabilized
with a steel spine down its center. For various gantry angles, these
high-density rails have the potential to attenuate the beam by more
than 40%, making it an obvious obstacle to avoid during patient
setup. Consequently, geometric methodologies were proposed to ensure
that beam-couch intersections were detected and dealt with
appropriately.(2-4)
The benefits of carbon fiber over
steel alloys make the new material a welcome change in radiotherapy
practice, but because of the general assumption that attenuation by
the couch is negligible, the strategies developed to avoid the couch
are now often ignored. There is still little literature regarding
the effects of carbon fiber patient support structures on clinical
dose distribution. In 1991, de Mooy(1)
characterized the properties of carbon fiber and introduced
applications of the material for use in radiation therapy. Meara and
Langmack(5) added to this
characterization by investigating the transmission and buildup
characteristics in 5-MV, 6-MV, and 8-MV beams for thin panels of
carbon fiber in combination with a variety of other plastics. The
majority of subsequent publications have focused on attenuation,
buildup, and increased skin dose caused by immobilization devices
and table inserts. de Ost et al.(6)
observed 1% attenuation through commercial carbon inserts in Co-60
and 6-MV beams, but also noted that the surface dose increased from
18% to 77% of maximum dose, and 21% to 55% of maximum dose,
respectively. Higgins et al.(7)
validated de Ost et al.'s results and concluded that there is
minimal attenuation due to the inserts but added that the magnitude
of the increase in surface dose was relatively larger for smaller
beam sizes. Butson et al.(8) quoted
similar results for a 6-MV photon beam. Carl and Vestergaard(9) suggested that carbon fiber materials
with thicknesses greater than 100 mg/cm2 should be avoided for 4-MV beams to reduce
skin dose in cases when the cumulative dose exceeds 54 Gy to 60 Gy.
McCormack et al.(10) extended
previously published results by examining beam attenuation by a
carbon fiber couch insert at various gantry angles. It was found
that a 6-MV photon beam was attenuated 2% at normal incidence and up
to 9% at oblique angles. In 2003, Vieira et al.(11) quantified the effect of carbon fiber
treatment couch rails in combination with assorted immobilization
devices on beam attenuation, reporting up to 15% attenuation of a
6-MV photon beam during head and neck treatments.
In this study, the attenuation of
photon beams traversing obliquely through the carbon fiber support
rails of a clinical treatment couch were examined. Attenuation of
beam fluence was measured in-air at two locations along the
treatment couch under various conditions for both 6- MV and 18-MV
photon beams. Dose reduction measurements were also made in-phantom.
By including the carbon fiber couch in the CT image of the phantom,
the effect of its attenuation on dose distribution was calculated
with a commercial treatment-planning system (Theraplan Plus v3.8,
Nucletron, Ottawa, ON, Canada). The calculations were compared to
measured data to investigate the ability of the planning system to
properly model the couch attenuation
II. MATERIALS AND METHODS
All measurements were performed on a Siemens Mevatron linear accelerator at The Ottawa Hospital Regional Cancer Centre. The treatment unit couch top was a Medtec indexed patient positioning system (IPPST) constructed with carbon fiber rails and grid panels. Measurements were made in-air and in-phantom using the geometry shown in Fig. 1. The in-air measurements were made with an RK Chamber (model 8305) and Keithley Therapy Dosimeter (model 35040). For in-air measurements, 0.4 cm and 0.8 cm thick brass caps provided buildup for 6-MV and 18-MV photon beam energies, respectively.(12) The in-phantom dose measurements were made at the center of a 20 × 20 × 20 cm3 acrylic block phantom with a NE 2571 ion chamber and NE 2570 electrometer.
Fig. 1. The experimental geometry for in-phantom measurement of dose reduction, calculated by the ratio of readings (a) with and (b) without the couch. In-air measurements were made under identical geometry except the phantom is replaced with brass buildup caps. |
||
|---|---|---|
Attenuation was
calculated by the ratio of the measurements taken under the two
conditions shown in Fig. 1. The measurements were made with and
without the carbon fiber couch rails attenuating the beam for 5 × 5
cm2 and 10 × 10 cm2 field sizes at both 6-MV and 18-MV photon
energies delivering 100 monitor units. In all cases, the gantry
angle was 225°, a beam orientation commonly used in standard
radiation therapy and an angle that maximizes the thickness of
carbon fiber material between the beam source and point of
measurement.
Figure 2 shows the
longitudinal intersection points of the beam central axis with the
couch. The in-air measurements were taken at locations A and C,
representing fields transiting through the solid and strut regions
of the couch, respectively. The in-phantom measurements were all
taken at a location within the grid region between positions B and
D. To investigate the longitudinal dependence of the beam
attenuation, the experimental setup was shifted along the
longitudinal axis of the treatment couch in increments of 1 cm
beginning at location B and ending at location D.
Fig. 2. Longitudinal intersection of the beam with the treatment couch. At location A the entire field intersects the solid carbon fiber region of the couch. At locations B through D the beam transits the open strut region of the couch. |
||
|---|---|---|
The experiment described above was also modeled in Theraplan Plus version 3.8. A CT dataset (3 mm slice thickness with 3 mm spacing) of the entire phantom sitting on the Medtec therapy couch as shown in Fig. 1(a) was acquired on the Philips AcQsim large bore, singleslice CT simulator (Philips Medical Systems, ON, Canada). The entire cross section of the treatment couch was included on each slice. The DICOM RT images were transferred to the treatment-planning system, where dose calculations were performed using the standard Theraplan dose calculation model with inhomogeneity correction turned on. Calculations were performed for two cases: the first where the Med-Tec couch was excluded from the calculation matrix and the second where it was included. In both cases, the CT tabletop was excluded from the treatment-planning calculations.
III. RESULTS
Attenuation of 6-MV and 18-MV photon beams by the carbon fiber side rails of the treatment tabletop was measured in-air for both 5 × 5 cm2 and 10 × 10 cm2 fields. The results are shown in Table 1. As expected, the attenuation is field size- and energy-dependent, the largest attenuation being 16.2% for smaller field sizes and lower energies. Attenuation is greatest near the head end of the tabletop (region A).
Table 1. In-air and in-phantom measurements of the effect of beam attenuation by the Medtec clinical treatment tabletop |
|---|
Measurements were
also made in-phantom under the geometric conditions shown in Fig.
1(a) and (b). The effect of beam attenuation on the dose at depth
in-phantom shows field size and energy dependence similar to the
in-air observations. At the point of measurement, 100 cm
source-to-axis distance, 14.1 cm depth, attenuation of the treatment
field by the tabletop reduces the dose by up to 7.4% and is shown in
the last column of Table 1.
To
determine how well the planning system mitigates this error,
comparison was made between the predictions of Theraplan Plus and
measurements. The results are shown in Table 2. The first column
under Dose Error compares measured and calculated dose when there is
no couch in the beam, and represents how well our model in Theraplan
Plus performs for this specific geometry. The second column compares
the routine clinical situation where the table is physically present
but ignored in planning. The final column shows the difference
between measured and calculated dose when the tabletop is included
in the Theraplan calculations. As shown, our model in Theraplan can
only predict dose for the geometry in question to about 3%. The
treatment table introduces a dose error up to 7.4% at the point of
interest. When we introduce the tabletop into the calculations,
Theraplan overcompensates for the table, but the total error becomes
less than 1.4%. Figure 3 shows the Theraplan calculated dose
distribution with and without the treatment couch.
Table 2. The difference between measured and calculated (TPP–Theraplan Plus) dose for 6-MV and 18-MV fields with and without attenuation from the treatment tabletop |
|---|
| Fig. 3. Theraplan isodose distributions calculated without (top) and with (bottom) the treatment couch included | ||
|---|---|---|
IV. DISCUSSION
Carbon fiber materials are often considered to be
effectively transparent to high-energy photons, particularly when
compared to materials previously used for radiotherapy support
structures, such as steel.(5) This is
reflected in the fact that no general purpose commercial
treatment-planning system provides a mechanism to account for the
treatment couch during the planning process. It should be noted that
Tomotherapy (TomoTherapy Incorporated, Madison, WI) planning systems
do provide such a capability. For beams passing through thin carbon
fiber meshes and table inserts, the assumption of transparency may
be clinically acceptable with the exception of surface dose effects
as described by Carl and Vestergaard(9)
Oblique treatment portals are
commonly used (e.g., tangential breast, oblique lung, six-field
prostate, and conformal brain), and, depending on the setup
geometry, beams may pass through the side rails of the treatment
couch. Under these conditions, dose reductions in-phantom of up to
7.4% were measured, while attenuation of up to 16.2% was measured
for beams traversing the solid carbon fiber panel region at the
superior end of the couch. If ignored, these are dose errors that
could be clinically significant. For example, an oblique opposed
pair for a lung boost could easily have the posterior beam passing
through the couch rails. In this case, for equally weighted beams,
the total localized dose error would be 3.7% or greater, depending
on the location of the patient on the couch.
It has been shown that a small
change in the dose can result in a much larger change in the local
response of the tissue. For example, Sanchez-Nieto and Nahum(12) suggest that for prostate cancer a dose
reduction of only 20% to 5% of the target volume can reduce the
tumor control probability (TCP) by as much as 18%. Mijnheer et
al.(13) concluded that an overall
accuracy of ±3.5% in the dose delivered to the ICRU reference point
is required. Clearly, the Fig. 3. Theraplan isodose distributions
calculated without (top) and with (bottom) the treatment couch
included localized dose error arising from ignoring couch
attenuation exceeds the recommended dose uncertainty and may result
in significant reductions in TCP. The assumption that carbon fiber
is radiation transparent is not valid, and ignoring the attenuation
can be clinically significant.
Mitigation of attenuation by beam
avoidance is difficult, particularly with indexed couches and
immobilization devices. One solution is to include the couch in the
dose calculation, although this is not straightforward due to the
structural differences between the CT couch and the LINAC couch.
This study has shown that the Theraplan Plus planning system can
predict the effect of the treatment couch on the dose distribution
to better than 3%.
We are
currently exploring methods to routinely merge CT images of the
treatment tabletop with patient CT scans. This involves replacing
the portion of the image containing the CT couch with a previously
acquired image of the treatment tabletop while maintaining the
integrity of the patient data. The spatial relationship between the
couch and the patient must be invariant between planning and
treatment for this approach to be robust. This requirement is true
for the lateral (IEC X) direction and to a lesser extent for the
longitudinal (IEC Y) direction. Clearly, left-to-right shifts in
patient position will result in the beam intersecting different
components of the treatment couch with varying attenuations. Thus,
the approach will require stringent patient indexing left to right.
The variation in attenuation moving longitudinally along the couch
has been explored. The results are shown in Fig. 4. It can be seen
that the attenuation varies by ±1.5% along the entire region
investigated, but by only ±0.5% over the portion of the couch
defined by the tabletop grid. Thus, the requirement for indexing
longitudinally is less stringent than left to right.
| Fig. 4. The dose reduction from attenuation by the tabletop at various positions along its length | ||
|---|---|---|
Radiotherapy techniques such as intensity-modulated radiotherapy use smaller field sizes and a variety of gantry angles, increasing the need to address this clinical problem. Routine consideration of couch attenuation requires that patients be positioned reproducibly by methods such as indexing.
V. CONCLUSION
This study investigated the dose error resulting from ignoring the beam attenuation by a carbon fiber treatment couch. It was found that neglecting this attenuation could result in clinically significant errors and that by including the treatment couch as part of the CT planning dataset, this error could be reduced significantly, even by a relatively simple dose calculation algorithm (pencil beam). We propose routine incorporation of the treatment couch as part of the treatment- planning dataset and have determined that this would require patient immobilization and indexing of the immobilization device with the treatment tabletop.
ACKNOWLEDGMENT
The Ottawa Regional Cancer Centre Foundation supported this research.
REFERENCES
- de Mooy LG. The use of carbon fibers in radiotherapy. Radiother Oncol. 1991;22(2):140-142.
- Meyer J, Mills JA, Haas OC, Burnham KJ, Parvin EA. Accommodation of couch constraints for coplanar intensity modulated radiation therapy. Radiother Oncol. 2001;61(1):23-32.
- Muthuswamy MS, Lam KL. A method of beam-couch intersection detection. Med Phys. 1999;26(2):229-235.
- Yorke ED. The geometry of avoiding beam intersections and blocking tray collisions. Med Phys. 1989;16(2):288-291.
- Meara SJP, Langmack KA. An investigation into the use of carbon fiber for megavoltage radiotherapy applications. Phys Med Biol. 1998;43(5):1359-1366.
- de Ost B, Vanregemorter J, Schaeken B, Van den Weyngaert D. The effect of carbon fiber inserts on the build-up and attenuation of high energy photon beams. Radiother Oncol. 1997;45(3):275-277.
- Higgins DM, Whitehurst P, Morgan AM. The effect of carbon fiber couch inserts on surface dose with beam size variation. Med Dosim. 2001;26(3):251-254.
- Butson MJ, Cheung T, Yu PKN, Webb B. Variations in skin dose associated with linac bed material at 6 MV x-ray energy. Phys Med Biol. 2002;47(2):N25-N30.
- Carl J, Vestergaard A. Skin damage probabilities using fixation materials in high-energy photon beams. Radiother Oncol. 2000;55(2):191-198.
- McCormack S, Diffey J, Morgan A. The effect of gantry angle on megavoltage photon beam attenuation by a carbon fiber couch insert. Med Phys. 2005;32(2):483-487.
- Vieira SC, Kaatee RSJP, Dirkx MLP, Heijmen BJM. Two-dimensional measurement of photon beam attenuation by the treatment couch and immobilization devices using an electronic portal imaging device. Med Phys. 2003;30(11):2981-2987.
- Sanchez-Nieto B, Nahum AE. The delta-TCP concept: A clinically useful measure of tumor control probability. Int J Rad Oncol Biol Phys. 1999;44(2):369-380.
- Mijnheer BJ, Battermann JJ, Wambersie A. What degree of accuracy is required and can be achieved in photon and neutron therapy. Radiother Oncol. 1987;8(3):237-252.